Literature DB >> 30641098

Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.

P Zachariah1, D E Freedberg2.   

Abstract

The optimal duration of contact precautions for vancomycin-resistant enterococcus (VRE)-colonized patients is uncertain and individual patient characteristics alone may not predict risk of prolonged colonization. Using a cohort of adult patients who underwent testing for VRE at intensive care unit (ICU) admission, we tested the association between local (unit-level) vancomycin use and persistent colonization with VRE. Higher unit-level vancomycin use significantly prolonged VRE colonization (P=0.03) independent of patient-level vancomycin use and unit VRE density.
Copyright © 2019 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibiotic use; Antimicrobial stewardship

Mesh:

Substances:

Year:  2019        PMID: 30641098      PMCID: PMC6589391          DOI: 10.1016/j.jhin.2019.01.008

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  8 in total

1.  Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients.

Authors:  R Patel; S L Allen; J M Manahan; A J Wright; R A Krom; R H Wiesner; D H Persing; F R Cockerill; R L Thompson
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

2.  Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients.

Authors:  M Papadimitriou-Olivgeris; E Drougka; F Fligou; F Kolonitsiou; A Liakopoulos; V Dodou; E D Anastassiou; E Petinaki; M Marangos; K S Filos; I Spiliopoulou
Journal:  Infection       Date:  2014-08-21       Impact factor: 3.553

3.  Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.

Authors:  Joyce Wang; Betsy Foxman; Lona Mody; Evan S Snitkin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

4.  The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.

Authors:  M J Zhou; J Li; H Salmasian; P Zachariah; Y-X Yang; D E Freedberg
Journal:  J Hosp Infect       Date:  2018-07-17       Impact factor: 3.926

5.  Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12-year retrospective cohort study.

Authors:  Surendra Karki; Gillian Land; Stacey Aitchison; Jacqueline Kennon; Paul D R Johnson; Susan A Ballard; Karin Leder; Allen C Cheng
Journal:  J Clin Microbiol       Date:  2013-08-07       Impact factor: 5.948

6.  Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.

Authors:  Kyung Mok Sohn; Kyong Ran Peck; Eun-Jeong Joo; Young Eun Ha; Cheol-In Kang; Doo Ryeon Chung; Nam Yong Lee; Jae-Hoon Song
Journal:  Int J Infect Dis       Date:  2012-11-26       Impact factor: 3.623

7.  Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed.

Authors:  Daniel E Freedberg; Hojjat Salmasian; Bevin Cohen; Julian A Abrams; Elaine L Larson
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

8.  The developing premature infant gut microbiome is a major factor shaping the microbiome of neonatal intensive care unit rooms.

Authors:  Brandon Brooks; Matthew R Olm; Brian A Firek; Robyn Baker; David Geller-McGrath; Sophia R Reimer; Karina R Soenjoyo; Jennifer S Yip; Dylan Dahan; Brian C Thomas; Michael J Morowitz; Jillian F Banfield
Journal:  Microbiome       Date:  2018-06-20       Impact factor: 14.650

  8 in total
  1 in total

1.  Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence-A Prospective Longitudinal Study.

Authors:  Carlos L Correa-Martinez; Verena B Stollenwerk; Annelene Kossow; Frieder Schaumburg; Alexander Mellmann; Stefanie Kampmeier
Journal:  Microorganisms       Date:  2019-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.